At the moment, the scientists behind the development of the AstraZeneca vaccine have announced that they have started testing a plague vaccine. The clinical trial is in its early stages and uses the same technology developed for the COVID-19 vaccine.
The Phase 1 study will see at least 40 healthy young people between the ages of 18 and 55 testing the vaccine, which uses the same technology as the coronavirus.
AstraZeneca has started testing a plague vaccine
The target of AstraZeneca is a centuries-old bacterial threat, plague, not the new pandemic virus.
For much of the world’s population, the plague is a lesson in history – the most infamous plague pandemic, the Black Death that swept through Europe in the 1300s, killed up to half the population. But there are still some cases in several rural areas in Africa, Asia and America. And in 2017, an outbreak killed 171 people in Madagascar. Antibiotics can now be used to treat the plague, if given early,
But many of the regions at risk of outbreaks are far away. An effective vaccine could provide a new way to protect lives. And the process will check how well the body recognizes and learns to fight the plague after vaccination.
The scheme of the vaccine against COVID-19 is similar to that used against COVID-19
Like the Oxford-AstraZeneca coronavirus vaccine, a weakened version of a common cold virus – adenovirus – is used in chimpanzees that has been genetically modified so that it cannot cause infection in humans.
This vaccine does not contain plague bacteria and therefore cannot cause plague. But it includes added genes that produce proteins from the plague bacterium Yersinia pestis. And this should teach the body’s immune system how to avoid the real infection, if it should ever do so.
Oxford-AstraZeneca officials have been at the center of several vaccine scandals
Since the launch of the AstraZeneca vaccine, several people have complained side effects. In fact, among the side effects reported by patients vaccinated with AstraZeneca serum, we find, in most cases:
Fever
Body pain
Headache
A predominance of these symptoms was observed in women.
Romania sells vaccine doses against COVID-19
In the context of vaccination against COVID-19, Romania is very poor in terms of vaccination. In other words, the country has ruled sale of vaccine doses. In other words, because the entire immunization campaign is taking place, the Romanian authorities have decided to sell doses of vaccine:
“Romania has concluded an agreement in principle for the sale of vaccine against COVID-19 to Ireland. This agreement includes 700,000 doses of Pfizer BioNTech with the very important mention that these doses are not needed at this time for the vaccination campaign in our country. We continue to have a sufficiently large number of doses in the country both for the continuation of the vaccination campaign and the eventuality of administration for the moment when a decision will be made if the decision will be made for the third dose “, said Andrei Baciu .
–
–
:quality(80)/cdn-kiosk-api.telegraaf.nl/e2092ad8-0005-11ec-939b-02c309bc01c1.jpg "FC Barcelona appoints ‘successor’ Lionel Messi | Football")
